Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERAP2 | Q6P179 | 15/20 | 0.48 |
| ▸ | LNPEP | Q9UIQ6 | 14/20 | 0.48 |
| ▸ | ERAP1 | Q9NZ08 | 7/20 | 0.47 |
| ▸ | TERT | O14746 | 2/20 | 0.39 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.38 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.38 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10198577 | 0.98 | ERAP2 (0.46) | ERAP2LNPEPERAP1TERTGNAI3 | |
| SCHEMBL10288432 | 0.96 | ERAP2 (0.42) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL85492 | 0.96 | ERAP2 (0.42) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL11927714 | 0.96 | ERAP2 (0.42) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL18116728 | 0.95 | ERAP2 (0.42) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL19445613 | 0.93 | ERAP2 (0.40) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL19445665 | 0.85 | TERT (0.35) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL10292404 | 0.85 | TERT (0.35) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL11947668 | 0.85 | TERT (0.35) | ERAP2LNPEPERAP1TERT | |
| SCHEMBL11927706 | 0.84 | ERAP2 (0.42) | ERAP2LNPEPERAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9457027-B2 | Compounds for use in treatment of mucostis | CELLCEUTIX CORPORATION (US) | 2016-10-04 | — | — | US | disclosed |